pharma news today glp-1 obesity drug Study predicts 16 new drugs may come to market Roche was among the first
Description
These appointments provide healthcare teams an opportunity to thoroughly assess any progress or challenges experienced by the patient during their treatment course
It stimulates insulin release and reduces the production of glucagon, resulting in lower blood glucose levels
They were first developed for the treatment of Type 2 Diabetes but over time it was found these medications also promoted weight loss
Ethics declarations Disclosures Nil
The Grover Lab at the University of California, Riverside released a preprint of Disintegration Fingerprinting: A low-cost and easy-to-use tool for identifying substandard and falsified medicines. The paper, which is not yet peer reviewed, describes a technique to identify solid-dosage drugs based on how they dissolve in liquid
At the small doses Im using (now at 250 g every 5 days), I do not have any reduction in weight
